Evaluation of role of Tigecycline among clinically significant multidrug resistant pathogens from a tertiary care hospital.
Annapoorna RemashPooja RaoSuchitra ShenoyShrikala BaligaShafir KassimPublished in: F1000Research (2024)
to tigecycline for elimination of infections caused by both Gram positive and Gram negative pathogens. The use of combination therapy becomes crucial to prevent the development of Pan Drug resistance.